FDA PIVOTAL TRIAL
What is REGAIN™?
REGAIN™ is our multicenter FDA pivotal trial designed to establish the safety and effectiveness of PeriPulse™. The REGAIN™ trial is officially registered at clinicaltrials.gov. We encourage you to click the link below to take a look at the full details.
A single 1-hour dose of bioelectronic therapy has been shown to accelerate and enhance recovery of a lacerated nerve[ref] following nerve repair. The REGAIN™ Trial will apply this same 1-hour bioelectronic paradigm in a traumatic nerve injury model.
If you want to read more about our technology, please visit our PeriPulse™ page for more information.
Traumatic nerve injuries tend to be the most severe and impactful to a patient. It takes many months or years to fully recover as nerves need to cross a substantial barrier, the nerve gap, prior to connecting with their targets. With the help of bioelectronic therapy using PeriPulse™, the timeline for recovery may be shortened.